September 2017 DAIDS Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements .

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Consortia for HIV/AIDS Vaccine Development (CHAVD)

For the published request for applications, see the February 7, 2018 Guide announcement, Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM1, Clinical Trial Not Allowed).

HIV Vaccine Research and Design (HIVRAD) Program

For the published program announcement with special receipt, referral, and/or review considerations, see the October 13, 2017 Guide announcement, HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

Advancing mAbs To Clear Early HIV Infection or Achieve a Sustained Virologic Remission

For the published request for applications, see the June 28, 2018 Guide announcement, Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01, Clinical Trial Required).

Advancing HIV Therapeutic Vaccine Science

For the published request for applications, see the April 25, 2018 Guide announcement, Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required).

Sustained Release Innovation for HIV

For the published request for applications, see the June 11, 2018 Guide announcement, Sustained Release Innovation for HIV (SRI) (R61/R33, Clinical Trial Optional).

Next Generation Multipurpose Prevention Technologies

For the published request for applications, see the September 12, 2017 Guide announcement, Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33-Clinical Trials Optional) .

Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States

For the published program announcement with special receipt, referral, and/or review considerations, see the November 16, 2017 Guide announcement, Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)

Content last reviewed on June 11, 2018